{"symbol": "EOLS", "companyName": "Evolus Inc.", "exchange": "NASDAQ Global Market", "industry": "Drug Manufacturers", "website": "https://www.evolus.com", "description": "Evolus Inc is engaged in providing physicians and their patients with expanded choices in medical aesthetic treatments and procedures. Its product candidate is an injectable formulation of a 900 kDa Botulinum toxin Type A complex.", "CEO": "David Moatazedi", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Drug Manufacturers - Specialty & Generic", "Drug Manufacturers"]}